Abiomed, Inc.
NASDAQ: ABMD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael Minogue
- Employees
- 2,003
- Headquarters
- Danvers, United States
- IPO year
- 1987
- Market cap
- $17.2B
- Website
- https://www.abiomed.com
Loading ABMD…
Loading profile data…Frequently asked questions about ABMD
What does Abiomed, Inc. (ABMD) do?
Abiomed, Inc. specializes in the creation and distribution of advanced medical technology designed to support or substitute the heart's pumping action in patients suffering from heart failure, while also offering ongoing care for these individuals. Its product portfolio includes various devices from the Impella family. The Impella 2.5 is a tiny...
Where does ABMD trade?
Abiomed, Inc. (ABMD) trades on the NASDAQ Global Select.
What sector is ABMD in?
Abiomed, Inc. (ABMD) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Abiomed, Inc.?
Michael Minogue is the chief executive officer of Abiomed, Inc. (ABMD).
Where is Abiomed, Inc. headquartered?
Abiomed, Inc. is headquartered in United States.
Does ABMD pay a dividend?
Abiomed, Inc. (ABMD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ABMD go public?
Abiomed, Inc. (ABMD) completed its initial public offering in 1987.